Global Tasimelteon Supply, Demand and Key Producers, 2026-2032
The global Tasimelteon market size is expected to reach $ 121 million by 2032, rising at a market growth of 1.4% CAGR during the forecast period (2026-2032).
Tasimelteon is a selective melatonin MT1 and MT2 receptor agonist used primarily for Non-24-Hour Sleep-Wake Disorder in adults and nighttime sleep disturbances associated with Smith-Magenis syndrome. It improves sleep timing and continuity through circadian rhythm regulation rather than conventional central nervous system sedation. Commercial dosage forms mainly include 20 mg capsules and a 4 mg/mL oral suspension. Upstream inputs include tasimelteon active pharmaceutical ingredient, capsule shells, fillers, suspending agents, thickeners, sweeteners, buffers, pharmaceutical bottles, and dosing devices. Downstream customers mainly include sleep medicine centers, neurology departments, genetic disorder specialists, pediatric departments, specialty pharmacies, hospital pharmacies, and regulated pharmaceutical distributors. The treated patient population is relatively small and requires specialist diagnosis, and the market consists mainly of the originator brand and a limited number of U.S. generic manufacturers, with an overall gross margin generally ranging from approximately 68% to 85%.
From the current market perspective, tasimelteon is primarily used for Non-24-Hour Sleep-Wake Disorder and nighttime sleep disturbances associated with Smith-Magenis syndrome. The addressable patient population is relatively limited, giving the market clear rare-disease and specialty-drug characteristics. Commercial demand is concentrated mainly in the United States, where the originator product retains advantages through indication coverage, a pediatric oral suspension, specialty pharmacy access, and patient support services, while the adult capsule segment has entered generic competition. Diagnosis depends heavily on sleep medicine, neurology, and genetic disorder specialists, resulting in a highly concentrated prescribing and distribution structure.
Looking ahead, the adult capsule segment will remain exposed to generic substitution and pricing pressure, while growth opportunities for the originator will increasingly depend on pediatric formulations, broader treatment coverage in Smith-Magenis syndrome, and development in additional circadian rhythm disorders. Oral suspension, weight-based dosing, and adherence support are expected to remain important areas of differentiation. Wider use of circadian rhythm monitoring, digital follow-up tools, and telemedicine may also improve patient identification, treatment assessment, and long-term therapy management.
Key market drivers include improving awareness of Non-24 among totally blind individuals, expansion of specialist sleep medicine services, and better diagnosis of rare genetic disorders. Patients with Smith-Magenis syndrome often require long-term management of sleep disturbances, and tasimelteon's defined receptor target and circadian rhythm mechanism support its role in structured specialist treatment. In addition, tasimelteon is not a conventional controlled sedative-hypnotic and carries a comparatively lower burden related to dependence and abuse management, which supports continued use under specialist supervision.
The main constraints include a narrow eligible patient population and a complex process of patient identification, diagnosis, and referral. High branded treatment costs, insurance access requirements, prior authorization, and patient affordability can directly limit treatment uptake. As generic capsules gain share, prescription volume may continue to increase, but average selling prices and originator revenue are likely to remain under pressure. Lower-cost alternatives such as melatonin, the absence of immediate sedative effects, and the need for consistent long-term dosing may also influence treatment selection and adherence.
This report studies the global Tasimelteon demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Tasimelteon, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tasimelteon that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Tasimelteon total market, 2021-2032, (USD Million)
Global Tasimelteon total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Tasimelteon total market, key domestic companies, and share, (USD Million)
Global Tasimelteon revenue by player, revenue and market share 2021-2026, (USD Million)
Global Tasimelteon total market by Type, CAGR, 2021-2032, (USD Million)
Global Tasimelteon total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Tasimelteon market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Vanda Pharmaceuticals, Teva Pharmaceutical Industries, Apotex, MSN Laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Tasimelteon market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Tasimelteon Market, By Region:
1. How big is the global Tasimelteon market?
2. What is the demand of the global Tasimelteon market?
3. What is the year over year growth of the global Tasimelteon market?
4. What is the total value of the global Tasimelteon market?
5. Who are the Major Players in the global Tasimelteon market?
6. What are the growth factors driving the market demand?
Tasimelteon is a selective melatonin MT1 and MT2 receptor agonist used primarily for Non-24-Hour Sleep-Wake Disorder in adults and nighttime sleep disturbances associated with Smith-Magenis syndrome. It improves sleep timing and continuity through circadian rhythm regulation rather than conventional central nervous system sedation. Commercial dosage forms mainly include 20 mg capsules and a 4 mg/mL oral suspension. Upstream inputs include tasimelteon active pharmaceutical ingredient, capsule shells, fillers, suspending agents, thickeners, sweeteners, buffers, pharmaceutical bottles, and dosing devices. Downstream customers mainly include sleep medicine centers, neurology departments, genetic disorder specialists, pediatric departments, specialty pharmacies, hospital pharmacies, and regulated pharmaceutical distributors. The treated patient population is relatively small and requires specialist diagnosis, and the market consists mainly of the originator brand and a limited number of U.S. generic manufacturers, with an overall gross margin generally ranging from approximately 68% to 85%.
From the current market perspective, tasimelteon is primarily used for Non-24-Hour Sleep-Wake Disorder and nighttime sleep disturbances associated with Smith-Magenis syndrome. The addressable patient population is relatively limited, giving the market clear rare-disease and specialty-drug characteristics. Commercial demand is concentrated mainly in the United States, where the originator product retains advantages through indication coverage, a pediatric oral suspension, specialty pharmacy access, and patient support services, while the adult capsule segment has entered generic competition. Diagnosis depends heavily on sleep medicine, neurology, and genetic disorder specialists, resulting in a highly concentrated prescribing and distribution structure.
Looking ahead, the adult capsule segment will remain exposed to generic substitution and pricing pressure, while growth opportunities for the originator will increasingly depend on pediatric formulations, broader treatment coverage in Smith-Magenis syndrome, and development in additional circadian rhythm disorders. Oral suspension, weight-based dosing, and adherence support are expected to remain important areas of differentiation. Wider use of circadian rhythm monitoring, digital follow-up tools, and telemedicine may also improve patient identification, treatment assessment, and long-term therapy management.
Key market drivers include improving awareness of Non-24 among totally blind individuals, expansion of specialist sleep medicine services, and better diagnosis of rare genetic disorders. Patients with Smith-Magenis syndrome often require long-term management of sleep disturbances, and tasimelteon's defined receptor target and circadian rhythm mechanism support its role in structured specialist treatment. In addition, tasimelteon is not a conventional controlled sedative-hypnotic and carries a comparatively lower burden related to dependence and abuse management, which supports continued use under specialist supervision.
The main constraints include a narrow eligible patient population and a complex process of patient identification, diagnosis, and referral. High branded treatment costs, insurance access requirements, prior authorization, and patient affordability can directly limit treatment uptake. As generic capsules gain share, prescription volume may continue to increase, but average selling prices and originator revenue are likely to remain under pressure. Lower-cost alternatives such as melatonin, the absence of immediate sedative effects, and the need for consistent long-term dosing may also influence treatment selection and adherence.
This report studies the global Tasimelteon demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Tasimelteon, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Tasimelteon that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Tasimelteon total market, 2021-2032, (USD Million)
Global Tasimelteon total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Tasimelteon total market, key domestic companies, and share, (USD Million)
Global Tasimelteon revenue by player, revenue and market share 2021-2026, (USD Million)
Global Tasimelteon total market by Type, CAGR, 2021-2032, (USD Million)
Global Tasimelteon total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Tasimelteon market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Vanda Pharmaceuticals, Teva Pharmaceutical Industries, Apotex, MSN Laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Tasimelteon market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Tasimelteon Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Capsules
- Oral Suspension
- Originator Drug
- Generic Drugs
- Adult Patients
- Pediatric Patients
- Hospital
- Clinic
- Other
- Vanda Pharmaceuticals
- Teva Pharmaceutical Industries
- Apotex
- MSN Laboratories
1. How big is the global Tasimelteon market?
2. What is the demand of the global Tasimelteon market?
3. What is the year over year growth of the global Tasimelteon market?
4. What is the total value of the global Tasimelteon market?
5. Who are the Major Players in the global Tasimelteon market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Tasimelteon Introduction
1.2 World Tasimelteon Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Tasimelteon Total Market by Region (by Headquarter Location)
1.3.1 World Tasimelteon Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Tasimelteon Revenue (2021-2032)
1.3.3 China Based Company Tasimelteon Revenue (2021-2032)
1.3.4 Europe Based Company Tasimelteon Revenue (2021-2032)
1.3.5 Japan Based Company Tasimelteon Revenue (2021-2032)
1.3.6 South Korea Based Company Tasimelteon Revenue (2021-2032)
1.3.7 ASEAN Based Company Tasimelteon Revenue (2021-2032)
1.3.8 India Based Company Tasimelteon Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Tasimelteon Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Tasimelteon Consumption Value (2021-2032)
2.2 World Tasimelteon Consumption Value by Region
2.2.1 World Tasimelteon Consumption Value by Region (2021-2026)
2.2.2 World Tasimelteon Consumption Value Forecast by Region (2027-2032)
2.3 United States Tasimelteon Consumption Value (2021-2032)
2.4 China Tasimelteon Consumption Value (2021-2032)
2.5 Europe Tasimelteon Consumption Value (2021-2032)
2.6 Japan Tasimelteon Consumption Value (2021-2032)
2.7 South Korea Tasimelteon Consumption Value (2021-2032)
2.8 ASEAN Tasimelteon Consumption Value (2021-2032)
2.9 India Tasimelteon Consumption Value (2021-2032)
3 WORLD TASIMELTEON COMPANIES COMPETITIVE ANALYSIS
3.1 World Tasimelteon Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Tasimelteon Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Tasimelteon in 2025
3.2.3 Global Concentration Ratios (CR8) for Tasimelteon in 2025
3.3 Tasimelteon Company Evaluation Quadrant
3.4 Tasimelteon Market: Overall Company Footprint Analysis
3.4.1 Tasimelteon Market: Region Footprint
3.4.2 Tasimelteon Market: Company Product Type Footprint
3.4.3 Tasimelteon Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Tasimelteon Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Tasimelteon Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Tasimelteon Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Tasimelteon Consumption Value Comparison
4.2.1 United States VS China: Tasimelteon Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Tasimelteon Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Tasimelteon Companies and Market Share, 2021-2026
4.3.1 United States Based Tasimelteon Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Tasimelteon Revenue, (2021-2026)
4.4 China Based Companies Tasimelteon Revenue and Market Share, 2021-2026
4.4.1 China Based Tasimelteon Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Tasimelteon Revenue, (2021-2026)
4.5 Rest of World Based Tasimelteon Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Tasimelteon Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Tasimelteon Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Tasimelteon Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Capsules
5.2.2 Oral Suspension
5.3 Market Segment by Type
5.3.1 World Tasimelteon Market Size by Type (2021-2026)
5.3.2 World Tasimelteon Market Size by Type (2027-2032)
5.3.3 World Tasimelteon Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY PRODUCT STATUS
6.1 World Tasimelteon Market Size Overview by Product Status: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Product Status
6.2.1 Originator Drug
6.2.2 Generic Drugs
6.3 Market Segment by Product Status
6.3.1 World Tasimelteon Market Size by Product Status (2021-2026)
6.3.2 World Tasimelteon Market Size by Product Status (2027-2032)
6.3.3 World Tasimelteon Market Size Market Share by Product Status (2027-2032)
7 MARKET ANALYSIS BY PATIENT GROUP
7.1 World Tasimelteon Market Size Overview by Patient Group: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Patient Group
7.2.1 Adult Patients
7.2.2 Pediatric Patients
7.3 Market Segment by Patient Group
7.3.1 World Tasimelteon Market Size by Patient Group (2021-2026)
7.3.2 World Tasimelteon Market Size by Patient Group (2027-2032)
7.3.3 World Tasimelteon Market Size Market Share by Patient Group (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Tasimelteon Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Clinic
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Tasimelteon Market Size by Application (2021-2026)
8.3.2 World Tasimelteon Market Size by Application (2027-2032)
8.3.3 World Tasimelteon Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Vanda Pharmaceuticals
9.1.1 Vanda Pharmaceuticals Details
9.1.2 Vanda Pharmaceuticals Major Business
9.1.3 Vanda Pharmaceuticals Tasimelteon Product and Services
9.1.4 Vanda Pharmaceuticals Tasimelteon Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Vanda Pharmaceuticals Recent Developments/Updates
9.1.6 Vanda Pharmaceuticals Competitive Strengths & Weaknesses
9.2 Teva Pharmaceutical Industries
9.2.1 Teva Pharmaceutical Industries Details
9.2.2 Teva Pharmaceutical Industries Major Business
9.2.3 Teva Pharmaceutical Industries Tasimelteon Product and Services
9.2.4 Teva Pharmaceutical Industries Tasimelteon Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Teva Pharmaceutical Industries Recent Developments/Updates
9.2.6 Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
9.3 Apotex
9.3.1 Apotex Details
9.3.2 Apotex Major Business
9.3.3 Apotex Tasimelteon Product and Services
9.3.4 Apotex Tasimelteon Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Apotex Recent Developments/Updates
9.3.6 Apotex Competitive Strengths & Weaknesses
9.4 MSN Laboratories
9.4.1 MSN Laboratories Details
9.4.2 MSN Laboratories Major Business
9.4.3 MSN Laboratories Tasimelteon Product and Services
9.4.4 MSN Laboratories Tasimelteon Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 MSN Laboratories Recent Developments/Updates
9.4.6 MSN Laboratories Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Tasimelteon Industry Chain
10.2 Tasimelteon Upstream Analysis
10.3 Tasimelteon Midstream Analysis
10.4 Tasimelteon Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Tasimelteon Introduction
1.2 World Tasimelteon Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Tasimelteon Total Market by Region (by Headquarter Location)
1.3.1 World Tasimelteon Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Tasimelteon Revenue (2021-2032)
1.3.3 China Based Company Tasimelteon Revenue (2021-2032)
1.3.4 Europe Based Company Tasimelteon Revenue (2021-2032)
1.3.5 Japan Based Company Tasimelteon Revenue (2021-2032)
1.3.6 South Korea Based Company Tasimelteon Revenue (2021-2032)
1.3.7 ASEAN Based Company Tasimelteon Revenue (2021-2032)
1.3.8 India Based Company Tasimelteon Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Tasimelteon Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Tasimelteon Consumption Value (2021-2032)
2.2 World Tasimelteon Consumption Value by Region
2.2.1 World Tasimelteon Consumption Value by Region (2021-2026)
2.2.2 World Tasimelteon Consumption Value Forecast by Region (2027-2032)
2.3 United States Tasimelteon Consumption Value (2021-2032)
2.4 China Tasimelteon Consumption Value (2021-2032)
2.5 Europe Tasimelteon Consumption Value (2021-2032)
2.6 Japan Tasimelteon Consumption Value (2021-2032)
2.7 South Korea Tasimelteon Consumption Value (2021-2032)
2.8 ASEAN Tasimelteon Consumption Value (2021-2032)
2.9 India Tasimelteon Consumption Value (2021-2032)
3 WORLD TASIMELTEON COMPANIES COMPETITIVE ANALYSIS
3.1 World Tasimelteon Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Tasimelteon Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Tasimelteon in 2025
3.2.3 Global Concentration Ratios (CR8) for Tasimelteon in 2025
3.3 Tasimelteon Company Evaluation Quadrant
3.4 Tasimelteon Market: Overall Company Footprint Analysis
3.4.1 Tasimelteon Market: Region Footprint
3.4.2 Tasimelteon Market: Company Product Type Footprint
3.4.3 Tasimelteon Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Tasimelteon Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Tasimelteon Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Tasimelteon Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Tasimelteon Consumption Value Comparison
4.2.1 United States VS China: Tasimelteon Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Tasimelteon Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Tasimelteon Companies and Market Share, 2021-2026
4.3.1 United States Based Tasimelteon Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Tasimelteon Revenue, (2021-2026)
4.4 China Based Companies Tasimelteon Revenue and Market Share, 2021-2026
4.4.1 China Based Tasimelteon Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Tasimelteon Revenue, (2021-2026)
4.5 Rest of World Based Tasimelteon Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Tasimelteon Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Tasimelteon Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Tasimelteon Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Capsules
5.2.2 Oral Suspension
5.3 Market Segment by Type
5.3.1 World Tasimelteon Market Size by Type (2021-2026)
5.3.2 World Tasimelteon Market Size by Type (2027-2032)
5.3.3 World Tasimelteon Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY PRODUCT STATUS
6.1 World Tasimelteon Market Size Overview by Product Status: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Product Status
6.2.1 Originator Drug
6.2.2 Generic Drugs
6.3 Market Segment by Product Status
6.3.1 World Tasimelteon Market Size by Product Status (2021-2026)
6.3.2 World Tasimelteon Market Size by Product Status (2027-2032)
6.3.3 World Tasimelteon Market Size Market Share by Product Status (2027-2032)
7 MARKET ANALYSIS BY PATIENT GROUP
7.1 World Tasimelteon Market Size Overview by Patient Group: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Patient Group
7.2.1 Adult Patients
7.2.2 Pediatric Patients
7.3 Market Segment by Patient Group
7.3.1 World Tasimelteon Market Size by Patient Group (2021-2026)
7.3.2 World Tasimelteon Market Size by Patient Group (2027-2032)
7.3.3 World Tasimelteon Market Size Market Share by Patient Group (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Tasimelteon Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Hospital
8.2.2 Clinic
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Tasimelteon Market Size by Application (2021-2026)
8.3.2 World Tasimelteon Market Size by Application (2027-2032)
8.3.3 World Tasimelteon Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Vanda Pharmaceuticals
9.1.1 Vanda Pharmaceuticals Details
9.1.2 Vanda Pharmaceuticals Major Business
9.1.3 Vanda Pharmaceuticals Tasimelteon Product and Services
9.1.4 Vanda Pharmaceuticals Tasimelteon Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Vanda Pharmaceuticals Recent Developments/Updates
9.1.6 Vanda Pharmaceuticals Competitive Strengths & Weaknesses
9.2 Teva Pharmaceutical Industries
9.2.1 Teva Pharmaceutical Industries Details
9.2.2 Teva Pharmaceutical Industries Major Business
9.2.3 Teva Pharmaceutical Industries Tasimelteon Product and Services
9.2.4 Teva Pharmaceutical Industries Tasimelteon Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Teva Pharmaceutical Industries Recent Developments/Updates
9.2.6 Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
9.3 Apotex
9.3.1 Apotex Details
9.3.2 Apotex Major Business
9.3.3 Apotex Tasimelteon Product and Services
9.3.4 Apotex Tasimelteon Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Apotex Recent Developments/Updates
9.3.6 Apotex Competitive Strengths & Weaknesses
9.4 MSN Laboratories
9.4.1 MSN Laboratories Details
9.4.2 MSN Laboratories Major Business
9.4.3 MSN Laboratories Tasimelteon Product and Services
9.4.4 MSN Laboratories Tasimelteon Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 MSN Laboratories Recent Developments/Updates
9.4.6 MSN Laboratories Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Tasimelteon Industry Chain
10.2 Tasimelteon Upstream Analysis
10.3 Tasimelteon Midstream Analysis
10.4 Tasimelteon Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Tasimelteon Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Tasimelteon Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Tasimelteon Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Tasimelteon Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Tasimelteon Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Tasimelteon Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Tasimelteon Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Tasimelteon Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Tasimelteon Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Tasimelteon Players in 2025
Table 12. World Tasimelteon Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Tasimelteon Company Evaluation Quadrant
Table 14. Head Office of Key Tasimelteon Players
Table 15. Tasimelteon Market: Company Product Type Footprint
Table 16. Tasimelteon Market: Company Product Application Footprint
Table 17. Tasimelteon Mergers & Acquisitions Activity
Table 18. United States VS China Tasimelteon Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Tasimelteon Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Tasimelteon Companies, Headquarters (States, Country)
Table 21. United States Based Companies Tasimelteon Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Tasimelteon Revenue Market Share (2021-2026)
Table 23. China Based Tasimelteon Companies, Headquarters (Province, Country)
Table 24. China Based Companies Tasimelteon Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Tasimelteon Revenue Market Share (2021-2026)
Table 26. Rest of World Based Tasimelteon Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Tasimelteon Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Tasimelteon Revenue Market Share (2021-2026)
Table 29. World Tasimelteon Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Tasimelteon Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Tasimelteon Market Size by Type (2027-2032) & (USD Million)
Table 32. World Tasimelteon Market Size by Product Status, (USD Million), 2021 & 2025 & 2032
Table 33. World Tasimelteon Market Size Value by Product Status (2021-2026) & (USD Million)
Table 34. World Tasimelteon Market Size by Product Status (2027-2032) & (USD Million)
Table 35. World Tasimelteon Market Size by Patient Group, (USD Million), 2021 & 2025 & 2032
Table 36. World Tasimelteon Market Size Value by Patient Group (2021-2026) & (USD Million)
Table 37. World Tasimelteon Market Size by Patient Group (2027-2032) & (USD Million)
Table 38. World Tasimelteon Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Tasimelteon Market Size by Application (2021-2026) & (USD Million)
Table 40. World Tasimelteon Market Size by Application (2027-2032) & (USD Million)
Table 41. Vanda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 42. Vanda Pharmaceuticals Major Business
Table 43. Vanda Pharmaceuticals Tasimelteon Product and Services
Table 44. Vanda Pharmaceuticals Tasimelteon Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Vanda Pharmaceuticals Recent Developments/Updates
Table 46. Vanda Pharmaceuticals Competitive Strengths & Weaknesses
Table 47. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 48. Teva Pharmaceutical Industries Major Business
Table 49. Teva Pharmaceutical Industries Tasimelteon Product and Services
Table 50. Teva Pharmaceutical Industries Tasimelteon Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Teva Pharmaceutical Industries Recent Developments/Updates
Table 52. Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 53. Apotex Basic Information, Manufacturing Base and Competitors
Table 54. Apotex Major Business
Table 55. Apotex Tasimelteon Product and Services
Table 56. Apotex Tasimelteon Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Apotex Recent Developments/Updates
Table 58. Apotex Competitive Strengths & Weaknesses
Table 59. MSN Laboratories Basic Information, Manufacturing Base and Competitors
Table 60. MSN Laboratories Major Business
Table 61. MSN Laboratories Tasimelteon Product and Services
Table 62. MSN Laboratories Tasimelteon Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. MSN Laboratories Recent Developments/Updates
Table 64. MSN Laboratories Competitive Strengths & Weaknesses
Table 65. Global Key Players of Tasimelteon Upstream (Raw Materials)
Table 66. Global Tasimelteon Typical Customers
Table 1. World Tasimelteon Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Tasimelteon Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Tasimelteon Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Tasimelteon Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Tasimelteon Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Tasimelteon Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Tasimelteon Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Tasimelteon Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Tasimelteon Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Tasimelteon Players in 2025
Table 12. World Tasimelteon Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Tasimelteon Company Evaluation Quadrant
Table 14. Head Office of Key Tasimelteon Players
Table 15. Tasimelteon Market: Company Product Type Footprint
Table 16. Tasimelteon Market: Company Product Application Footprint
Table 17. Tasimelteon Mergers & Acquisitions Activity
Table 18. United States VS China Tasimelteon Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Tasimelteon Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Tasimelteon Companies, Headquarters (States, Country)
Table 21. United States Based Companies Tasimelteon Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Tasimelteon Revenue Market Share (2021-2026)
Table 23. China Based Tasimelteon Companies, Headquarters (Province, Country)
Table 24. China Based Companies Tasimelteon Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Tasimelteon Revenue Market Share (2021-2026)
Table 26. Rest of World Based Tasimelteon Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Tasimelteon Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Tasimelteon Revenue Market Share (2021-2026)
Table 29. World Tasimelteon Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Tasimelteon Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Tasimelteon Market Size by Type (2027-2032) & (USD Million)
Table 32. World Tasimelteon Market Size by Product Status, (USD Million), 2021 & 2025 & 2032
Table 33. World Tasimelteon Market Size Value by Product Status (2021-2026) & (USD Million)
Table 34. World Tasimelteon Market Size by Product Status (2027-2032) & (USD Million)
Table 35. World Tasimelteon Market Size by Patient Group, (USD Million), 2021 & 2025 & 2032
Table 36. World Tasimelteon Market Size Value by Patient Group (2021-2026) & (USD Million)
Table 37. World Tasimelteon Market Size by Patient Group (2027-2032) & (USD Million)
Table 38. World Tasimelteon Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Tasimelteon Market Size by Application (2021-2026) & (USD Million)
Table 40. World Tasimelteon Market Size by Application (2027-2032) & (USD Million)
Table 41. Vanda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 42. Vanda Pharmaceuticals Major Business
Table 43. Vanda Pharmaceuticals Tasimelteon Product and Services
Table 44. Vanda Pharmaceuticals Tasimelteon Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Vanda Pharmaceuticals Recent Developments/Updates
Table 46. Vanda Pharmaceuticals Competitive Strengths & Weaknesses
Table 47. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 48. Teva Pharmaceutical Industries Major Business
Table 49. Teva Pharmaceutical Industries Tasimelteon Product and Services
Table 50. Teva Pharmaceutical Industries Tasimelteon Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Teva Pharmaceutical Industries Recent Developments/Updates
Table 52. Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 53. Apotex Basic Information, Manufacturing Base and Competitors
Table 54. Apotex Major Business
Table 55. Apotex Tasimelteon Product and Services
Table 56. Apotex Tasimelteon Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Apotex Recent Developments/Updates
Table 58. Apotex Competitive Strengths & Weaknesses
Table 59. MSN Laboratories Basic Information, Manufacturing Base and Competitors
Table 60. MSN Laboratories Major Business
Table 61. MSN Laboratories Tasimelteon Product and Services
Table 62. MSN Laboratories Tasimelteon Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. MSN Laboratories Recent Developments/Updates
Table 64. MSN Laboratories Competitive Strengths & Weaknesses
Table 65. Global Key Players of Tasimelteon Upstream (Raw Materials)
Table 66. Global Tasimelteon Typical Customers
LIST OF FIGURES
Figure 1. Tasimelteon Picture
Figure 2. World Tasimelteon Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Tasimelteon Total Revenue (2021-2032) & (USD Million)
Figure 4. World Tasimelteon Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Tasimelteon Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Tasimelteon Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Tasimelteon Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Tasimelteon Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Tasimelteon Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Tasimelteon Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Tasimelteon Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Tasimelteon Revenue (2021-2032) & (USD Million)
Figure 13. Tasimelteon Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Tasimelteon Consumption Value (2021-2032) & (USD Million)
Figure 16. World Tasimelteon Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Tasimelteon Consumption Value (2021-2032) & (USD Million)
Figure 18. China Tasimelteon Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Tasimelteon Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Tasimelteon Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Tasimelteon Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Tasimelteon Consumption Value (2021-2032) & (USD Million)
Figure 23. India Tasimelteon Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Tasimelteon by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Tasimelteon Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Tasimelteon Markets in 2025
Figure 27. United States VS China: Tasimelteon Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Tasimelteon Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Tasimelteon Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Tasimelteon Market Size Market Share by Type in 2025
Figure 31. Capsules
Figure 32. Oral Suspension
Figure 33. World Tasimelteon Market Size Market Share by Type (2021-2032)
Figure 34. World Tasimelteon Market Size by Product Status, (USD Million), 2021 & 2025 & 2032
Figure 35. World Tasimelteon Market Size Market Share by Product Status in 2025
Figure 36. Originator Drug
Figure 37. Generic Drugs
Figure 38. World Tasimelteon Market Size Market Share by Product Status (2021-2032)
Figure 39. World Tasimelteon Market Size by Patient Group, (USD Million), 2021 & 2025 & 2032
Figure 40. World Tasimelteon Market Size Market Share by Patient Group in 2025
Figure 41. Adult Patients
Figure 42. Pediatric Patients
Figure 43. World Tasimelteon Market Size Market Share by Patient Group (2021-2032)
Figure 44. World Tasimelteon Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 45. World Tasimelteon Market Size Market Share by Application in 2025
Figure 46. Hospital
Figure 47. Clinic
Figure 48. Other
Figure 49. World Tasimelteon Market Size Market Share by Application (2021-2032)
Figure 50. Tasimelteon Industrial Chain
Figure 51. Methodology
Figure 52. Research Process and Data Source
Figure 1. Tasimelteon Picture
Figure 2. World Tasimelteon Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Tasimelteon Total Revenue (2021-2032) & (USD Million)
Figure 4. World Tasimelteon Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Tasimelteon Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Tasimelteon Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Tasimelteon Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Tasimelteon Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Tasimelteon Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Tasimelteon Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Tasimelteon Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Tasimelteon Revenue (2021-2032) & (USD Million)
Figure 13. Tasimelteon Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Tasimelteon Consumption Value (2021-2032) & (USD Million)
Figure 16. World Tasimelteon Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Tasimelteon Consumption Value (2021-2032) & (USD Million)
Figure 18. China Tasimelteon Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Tasimelteon Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Tasimelteon Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Tasimelteon Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Tasimelteon Consumption Value (2021-2032) & (USD Million)
Figure 23. India Tasimelteon Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Tasimelteon by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Tasimelteon Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Tasimelteon Markets in 2025
Figure 27. United States VS China: Tasimelteon Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Tasimelteon Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Tasimelteon Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Tasimelteon Market Size Market Share by Type in 2025
Figure 31. Capsules
Figure 32. Oral Suspension
Figure 33. World Tasimelteon Market Size Market Share by Type (2021-2032)
Figure 34. World Tasimelteon Market Size by Product Status, (USD Million), 2021 & 2025 & 2032
Figure 35. World Tasimelteon Market Size Market Share by Product Status in 2025
Figure 36. Originator Drug
Figure 37. Generic Drugs
Figure 38. World Tasimelteon Market Size Market Share by Product Status (2021-2032)
Figure 39. World Tasimelteon Market Size by Patient Group, (USD Million), 2021 & 2025 & 2032
Figure 40. World Tasimelteon Market Size Market Share by Patient Group in 2025
Figure 41. Adult Patients
Figure 42. Pediatric Patients
Figure 43. World Tasimelteon Market Size Market Share by Patient Group (2021-2032)
Figure 44. World Tasimelteon Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 45. World Tasimelteon Market Size Market Share by Application in 2025
Figure 46. Hospital
Figure 47. Clinic
Figure 48. Other
Figure 49. World Tasimelteon Market Size Market Share by Application (2021-2032)
Figure 50. Tasimelteon Industrial Chain
Figure 51. Methodology
Figure 52. Research Process and Data Source
